Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Chao NJ, Snyder DS, Jain M, Wong RM, Niland JC, Negrin RS, Long GD, Hu WW, Stockerl-Goldstein KE, Johnston LJ, Amylon MD, Tierney DK, O'Donnell MR, Nademanee AP, Parker P, Stein A, Molina A, Fung H, Kashyap A, Kohler S, Spielberger R, Krishnan A, Rodriguez R, Forman SJ, Bluzme KG. Chao NJ, et al. Among authors: tierney dk. Biol Blood Marrow Transplant. 2000;6(3):254-61. doi: 10.1016/s1083-8791(00)70007-3. Biol Blood Marrow Transplant. 2000. PMID: 10871150 Free article. Clinical Trial.
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
Chao NJ, Parker PM, Niland JC, Wong RM, Dagis A, Long GD, Nademanee AP, Negrin RS, Snyder DS, Hu WW, Gould KA, Tierney DK, Zwingenberger K, Forman SJ, Blume KG. Chao NJ, et al. Among authors: tierney dk. Biol Blood Marrow Transplant. 1996 May;2(2):86-92. Biol Blood Marrow Transplant. 1996. PMID: 9118303 Clinical Trial.
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA. Boeckh M, et al. Among authors: tierney dk. Biol Blood Marrow Transplant. 2001;7(6):343-51. doi: 10.1016/s1083-8791(01)80005-7. Biol Blood Marrow Transplant. 2001. PMID: 11464977 Free article. Clinical Trial.
Intensive Care Utilization for Hematopoietic Cell Transplant Recipients.
Jenkins P, Johnston LJ, Pickham D, Chang B, Rizk N, Tierney DK. Jenkins P, et al. Among authors: tierney dk. Biol Blood Marrow Transplant. 2015 Nov;21(11):2023-7. doi: 10.1016/j.bbmt.2015.07.026. Epub 2015 Jul 31. Biol Blood Marrow Transplant. 2015. PMID: 26238809 Free article.
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, Kent EE, Jacobsen PB, Lee SJ, Hsieh MM, Denzen EM, Syrjala KL. Bevans M, et al. Among authors: tierney dk. Biol Blood Marrow Transplant. 2017 Apr;23(4):538-551. doi: 10.1016/j.bbmt.2016.09.011. Epub 2016 Sep 19. Biol Blood Marrow Transplant. 2017. PMID: 27660168 Free PMC article. Review.
29 results